Sotac Pharmaceuticals Ltd

Sotac Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sotac Pharmaceuticals Ltd

₹ 136 -4.88%
26 Sep - close price
Company website NSE - SME: SOTAC
About

Incorporated in 2015, Co. is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis[1]

Key Points

Business Verticals
A) Manufacturing of Non-Beta-Lactam Medicines and Formulations [1]
It manufactures Non-Beta-Lactam (general) tablets, Non-Beta-Lactam (general) capsules, oral liquid, dry syrup, and external preparations such as Ointment, Lotion, and cream and caters to 162 corporate clients on a loan license and/or contract manufacturing basis

Website NSE - ST
  • Market Cap ₹ 150 Cr.
  • Current Price ₹ 136
  • High / Low ₹ 203 / 87.1
  • Stock P/E 31.3
  • Book Value ₹ 41.0
  • Dividend Yield 0.00 %
  • ROCE 10.0 %
  • ROE 11.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 3.31 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Working capital days have increased from 60.2 days to 92.3 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
19.87 39.75 19.65 18.08 24.97 26.67 25.74 26.45 25.25
17.96 36.35 17.88 15.67 22.63 24.58 22.82 25.27 23.03
Operating Profit 1.91 3.40 1.77 2.41 2.34 2.09 2.92 1.18 2.22
OPM % 9.61% 8.55% 9.01% 13.33% 9.37% 7.84% 11.34% 4.46% 8.79%
0.07 0.78 0.01 0.14 0.23 0.05 0.38 0.35 0.25
Interest 0.29 1.06 0.27 0.64 0.46 0.67 0.99 0.35 0.42
Depreciation 0.50 1.11 0.56 0.61 0.60 0.78 0.83 0.88 0.75
Profit before tax 1.19 2.01 0.95 1.30 1.51 0.69 1.48 0.30 1.30
Tax % 54.62% 49.25% 38.95% 20.77% 34.44% 68.12% 39.86% -403.33% -3.85%
0.54 1.02 0.57 1.04 1.08 0.65 0.90 1.64 1.45
EPS in Rs 2.35 4.43 0.71 1.29 0.98 0.59 0.81 1.48 1.31
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023 Mar 2024 TTM
29 49 77 104 104
27 47 70 95 96
Operating Profit 2 1 7 9 8
OPM % 7% 3% 10% 8% 8%
0 0 1 0 1
Interest 0 1 2 2 2
Depreciation 1 3 2 3 3
Profit before tax 0 -2 4 4 4
Tax % 75% 15% 42% 10%
0 -2 2 4 5
EPS in Rs 0.39 -10.30 3.58 3.87 4.19
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 29%
TTM: 2%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 52%
TTM: 38%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 9%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023 Mar 2024
Equity Capital 2 2 8 11
Reserves 1 0 11 34
13 17 22 25
14 15 32 35
Total Liabilities 30 35 74 105
16 17 26 36
CWIP 0 0 0 5
Investments 0 0 0 2
14 18 48 63
Total Assets 30 35 74 105

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023 Mar 2024
0 -0 8 -16
-12 -3 -12 -20
11 3 13 30
Net Cash Flow -0 -0 10 -6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023 Mar 2024
Debtor Days 89 44 70 92
Inventory Days 40 45 87 83
Days Payable 194 121 162 132
Cash Conversion Cycle -66 -32 -5 43
Working Capital Days 14 15 28 92
ROCE % -5% 10%

Shareholding Pattern

Numbers in percentages

Apr 2023Sep 2023Mar 2024
72.85% 72.85% 72.85%
12.88% 8.51% 8.99%
14.27% 18.64% 18.16%
No. of Shareholders 784255245

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports